Browsing by keyword "medication assisted treatment"
Now showing items 1-2 of 2
-
Individualized Treatment and Understanding the Non-Pharmacologic Components that are Part of RecoveryLearn about the non-pharmacologic components of recovery. When developing individualized treatment plans, what factors are considered? The Medical Director and the Director of Quality and Compliance for Washburn House, a new treatment facility in Worcester, Massachusetts, will share their stories of starting a new treatment facility, and the challenges of putting evidence-based practices into practical use. Learning Objectives: Individualized Treatment and Understanding the non-pharmacologic Components that are Part of Recovery Understand the rationale and treatment options for managed withdrawal of a patient with opioid use disorder Understand the rationale and treatment options for Medication Assisted Treatment in a patient with opioid use disorder Understand the non-pharmacologic components that are part of recovery
-
Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomesBackground: Our rural health system sought to (1) increase the number of primary care clinicians waivered to prescribe buprenorphine for treatment of opioid use disorder (OUD) and (2) consequently increase the number of our patients receiving this treatment. Methods: We used the Project for Extension for Community Health Outcomes (ECHO) tele-education model as an implementation strategy. We examined the number of clinicians newly waivered, the number of patients treated with buprenorphine, the relationship between clinician engagement with ECHO training and rates of buprenorphine prescribing, and treatment retention at 180 days. Results: The number of clinicians with a waiver and number of patients treated increased during and after ECHO training. There was a moderate correlation between the number of ECHO sessions attended by a clinician and number of their buprenorphine prescriptions (r = 0.50, p = 0.01). The 180-day retention rate was 80.7%. Conclusions: Project ECHO was highly effective for increasing access to this evidence-based treatment. The high retention rate in this rural context indicates that most patients are increasing their likelihood of favorable outcomes.
